Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1989-4-28
pubmed:abstractText
Evidence accumulated over the last decade concerning human and experimental models suggests that an immunopathological mechanism may be involved in the pathogenesis of chronic Chagas' disease. In this paper we demonstrate the existence of two different circulating IgG in chagasic patients which bind with myocardial beta 1 and spleen cell beta 2 adrenoceptors, acting as non-competitive inhibitors. Both chagasic IgG against beta 1 and beta 2 adrenoceptor increased intracellular levels of cAMP that could be blocked by specific beta 1 and beta 2 adrenoceptor antagonists. The specificity for beta 1 and beta 2 adrenoceptors and the independence of other tissue reactive antibodies was demonstrated by IgG absorption with turkey red blood cell (TRBC), human lymphocytes (HL) or guinea pig red blood cells (GPRBC). The F(ab')2 fraction acted similarly. This supports the specificity of beta 1 and beta 2 adrenoceptors to the chagasic IgG and the independence of the other tissue reactive antibodies, such as EVI system. The probable pathogenic role of both beta 1 and beta 2 adrenergic chagasic antibody is discussed.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-103414, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-1245597, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-212062, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-229209, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-2878709, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-2880270, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-3017873, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-3022741, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-3025114, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-3098693, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-3871361, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-402815, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-4128626, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-4140227, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-6036174, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-6088139, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-6261254, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-6415490, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-6421518, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-6801186, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-812625, http://linkedlifedata.com/resource/pubmed/commentcorrection/2853016-825225
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
349-54
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Antibodies to beta 1 and beta 2 adrenoreceptors in Chagas' disease.
pubmed:affiliation
Centro de Estudios Farmacológicos y de Principios Naturales, Buenos Aires, Argentina.
pubmed:publicationType
Journal Article